Delivery Order SPE2DB22D2006-SPE2DB25FW3JE
- Not listed
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The Defense Logistics Agency awarded a $6,142.80 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextroses on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,662,455 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract has a ceiling value of $15,175.44 and an ultimate completion date of September 4, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical supplies to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,387.34, is for the supply of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract is a firm-fixed-price, non-set-aside delivery order with a completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,373.84 for Cefazolin 1 GM vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 g/50 mL-dextrose, a critical pharmaceutical product. The delivery order, valued at $20,603.94, has a firm fixed price and an ultimate completion date of September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,445.28 firm fixed price contract is for the delivery of Cefazolin 2 g/50 ml-dextrose, a critical antibiotic medication, with a performance period through November 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a wide range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,702.04 firm fixed-price contract is for the delivery of CEFAZOLIN 1 G/50 ML-DEXTROSES, a pharmaceutical product. The delivery order is not set aside and was awarded on June 13, 2025, with a completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a $4,319.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 1 G/50 ML-Dextroses, a type of antibiotic medication, with a period of performance through July 7, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $4,335.84 and an ultimate completion date of August 13, 2024. It is a firm fixed-price contract, with no set-aside designation....
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3JEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Cefazolin 2 G/50 ML in dextrose solution, valued at $1,200.22. This firm fixed price delivery order, which will be completed by August 13, 2025, represents a pediatric or small-volume pharmaceutical procurement with performance in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting open competition among qualified pharmaceutical suppliers. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of diverse medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Through this arrangement, AmerisourceBergen Drug Corp supplies critical pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning the company as a primary vendor for DLA medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/12/25 |